HSF1 and neoplasm: Indeed, many of the HSP90 activity inhibitors stimulate the HSF1 activation-mediated induction of HSP70, HSP27 and MDR1, which can elevate the radioprotective and adaptive potential of the tumor cells that survived after the inhibitory treatment.